Hot Investor Mandate: Venture-to-Growth Fund Invests in Clinical-Stage Devices, Diagnostics and Regenerative Medicine

13 Dec

A large investment firm invests in venture to growth-stage startups. For their earlier stage investments, the firm will invest in medical devices, diagnostics and digital health companies. For devices and diagnostics, The firm prefers to invest in clinical-stage technologies, but will not invest in devices that require PMA approval. However, the firm is interested in regenerative medicine technologies of any stage. The firm is also interested in digital health companies at any stage. The firm is looking to invest between $5-15M for an initial investment in US-based companies.

The firm is interested in medical devices, diagnostics, digital health and regenerative medicine, but is indication agnostic within these sectors. The firm will not invest in medical devices that require PMA approval, unless they fall under the category of regenerative medicine.

The firm is a lead investor, and takes a board seat for their portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: